Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Stomasense: una nuova via per il rilevamento proattivo e la gestione delle perdite all'interno delle sacche di ostomia

10 novembre 2026 aggiornato da: University of Ulster

People living with an ileostomy may often experience leaks from their stoma pouches. Leakages are a highly stressful experience, so it is no surprise that worry about leaks is very common among ileostomates and this can contribute to increased anxiety and impact negatively on quality of life. Ileostomates will make changes to their lifestyle to minimise the occurrence of leaks; they may avoid travelling long distances, steer clear of busy social events and often restrict certain food(s) and / or drink(s). The latter stands in the way of achieving a healthy balanced diet and can put ileostomates at risk of developing nutritional deficiencies.

Researchers at ulster university have developed a leak sensor device which can be worn unobtrusively alongside any stoma pouch. The device can detect the early stages of a leak from the stoma bag and alerts the user, meaning they are able to change their pouch before it's too late. Participants will be asked to trial 2 versions of the device, each over a 2-week period. At the beginning and end of each period participants will complete a series of questionnaires to allow the research team to determine device efficacy and impact on quality of life. Food diaries will also be completed by participants to give an indication of how dietary intake can impact the incidence of pouch leakage.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Surgical diversion of the bowel to create an opening in the abdomen (stoma) is a common procedure in the treatment of various gastrointestinal conditions; 21 000 stomas are created in the UK each year and it is estimated that 176 000 - 205 000 individuals in the UK are living with a stoma. This is a life-changing operation which requires significant physical and psychological adaptation particularly as bowel/bladder content is collected in a disposable pouch that adheres to the abdomen. Leakage, especially in public, is a constant worry resulting in decreased social interactions, increased anxiety and depression and can have a tremendous impact on family and work life. The extent of the problem was confirmed by the Ostomy Life Study (2015) which surveyed some 4000 ostomates from 11 different countries and found the majority (91%) of participants reported that leakage of the pouch was a concern with 69% confirming that it was their prime worry and greatly impacted on their quality of life (QoL). Leakage events are very traumatic emotionally and will impact an individual's practical management of their ostomy; stoma effluent in contact with the epidermal layer is a major contributing factor in the development of peristomal skin complications (PCS), this in turn can cause difficulty in adhesion of the baseplate to the affected skin, therefore further contributing to the future leaks.

To put an end to this cycle of worsening skin integrity and subsequent increased frequency of leaks, new leak sensor technology has been developed by Ulster University which can be used with any stoma pouch system to detect the early onset of stoma pouch failure - providing an alert that allows the patient to replace the pouch before catastrophic seepage of bowel/bladder content.

Whilst this new leak sensor technology will be extremely useful in the early detection of leaks, it is important to also consider how an individual's management of their stoma, as well as health and lifestyle behaviours, could be manipulated to further reduce the incidence of leaks and improve QoL. In a previous study, participants identified food consumption (i.e., eating certain foods) as being the most prominent contributor to the incidence of leaks. It has been reported that fruit and vegetables are avoided by ostomates - in particular those with an ileostomy - to help minimise the risk of leaks. Obviously, this is less than ideal, considering the well-established health benefits of consuming a diet rich in fruit and vegetables. At present, there is no evidence confirming the efficacy of restricting dietary intake to reduce the frequency of leaks. Therefore, it is possible that people living with a stoma are unnecessarily restricting their dietary intake and putting themselves at risk of various nutrient deficiencies and associated health conditions.

The over-riding aim of the current proposal is to validate a smart device that can be worn unobtrusively alongside existing stoma pouch systems whilst monitoring the condition of the adhesive skin wafer, such that erosion of the bond can be detected before a leak occurs. This would enable the wearer to replace the pouch avoiding the consequences of leakage and accompanying distress, therefore improving QoL and psychological well-being. The impact of the device on participant well-being will be assessed using a series of validated questionnaires. The sensor is not a medical device as it only interacts with the stoma bag and flange and does not interact directly with the participant or their bodily fluids.

The sensing device will:

  1. Accurately detect the onset of leaks.
  2. Provide a discrete personal alert (vibration).
  3. Allow for wireless connectivity for those requiring carer / nursing support.
  4. Allow for differences in patient dexterity; two distinct probe systems (microbutton or microwire sensor) will be validated.

Therefore, this study seeks to test the sensor technology with ileostomates in a cross over study involving microbutton and microwire sensors. This study hopes to achieve an 85% success rate in the accurate detection of leaks.

The secondary aim of this study is to determine associations between dietary intake and the incidence of leakages. This information will have the potential to inform the development of dietary guidelines for those living with a stoma, and to therefore improve overall nutritional status and health of this patient group.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

50

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Co. Derry
      • Coleraine, Co. Derry, Regno Unito, BT521SA
        • Ulster University, Human Intervention Studies Unit

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Living with an ileostomy
  • ≥1.5-years post-operative
  • Aged 18+ years
  • Experiencing frequent leaks (i.e., more than once per week)
  • Males and females (not currently pregnant/lactating)
  • Self-manging their own stoma
  • Access to computer / mobile device for survey completion
  • No learning or other disabilities
  • Have never used / trialled other leak detection systems

Exclusion Criteria:

  • Never had an ileostomy,
  • Individuals with previous ileostomy or ostomy (colostomy or urostomy)
  • <1.5-year post-operative
  • <18 years
  • Do not experience frequent leaks (i.e., less than once per week)
  • Adults with learning or other disabilities
  • Have previously used other leak detection systems
  • Pregnant/lactating female

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Triplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Leak detection device (microbutton probes)

Leakage events will be detected by microbutton probes, which are attached to the sensing device

A smart device worn alongside stoma pouch systems which detects onset of a leak.

Sperimentale: Leak detection device (microwire probes)

Leakage events will be detected by microwire probes, which are attached to the sensing device

A smart device worn alongside stoma pouch systems which detects onset of a leak.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Psychiatric morbidity
Lasso di tempo: Comparison between treatments over a 2-week period.

Psychiatric morbidity will be assessed at the beginning and end of each test period using the General Health Questionnaire (GHQ-12).

Comparison between treatments over a 2-week period.
Psychological well-being
Lasso di tempo: Comparison between treatments over a 2-week period.

Psychological well-being will be assessed at the beginning and end of each test period using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS)

Comparison between treatments over a 2-week period.
General quality of life
Lasso di tempo: Comparison between treatments over a 2-week period.

General quality of life will be assessed at the beginning and end of each test period using the European Organization for Research and Treatment of Cancer (EORTC) QoL questionnaire for colorectal cancer (EORTCQLQ-CR38).

Comparison between treatments over a 2-week period.
General quality of life
Lasso di tempo: Comparison between treatments over a 2-week period.

General quality of life will be assessed at the beginning and end of each test period using the The World Health Organization Quality of Life - BREF (WHOQOL-BREF).

Comparison between treatments over a 2-week period.
Stress and coping
Lasso di tempo: Change over 2 weeks comparison between treatments

Stress and coping will be assessed at the beginning and end of each test period using the Perceived Stress Scale (PSS), which is a global measure of stress

Change over 2 weeks comparison between treatments
Resillience
Lasso di tempo: Change over 2 weeks comparison between treatments

Resillience will be assessed at the beginning and end of each test period using the Connor-Davidson Resilience Scale (CD-RISC)

Change over 2 weeks comparison between treatments
Stoma related quality of life
Lasso di tempo: Comparison between treatments over a 2-week period.

Stoma related quality of life will be assessed at the beginning and end of each test period using the Stoma QoL: A Quality-of-Life Questionnaire for People with an Ostomy

Comparison between treatments over a 2-week period.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Device accuracy
Lasso di tempo: Measured over 2 weeks comparison between treatments

Participants will keep a daily leak diary in which the incidence of leaks will be recorded. Participants will log leakage events as true positive (TP; successful detection of leak), false positive (FP; sensor alert but no leak occurred) or false negative (FN; occurrence of leak but no alert from device).

Measured over 2 weeks comparison between treatments
Device usability
Lasso di tempo: Measured at 2 weeks comparison between treatments

Participants will complete a user experience survey at the end of each treatment period.

Measured at 2 weeks comparison between treatments
Dietary intake
Lasso di tempo: Measured over 2 weeks comparison between treatments

Participants will complete 4-day food diaries at the beginning and end of each treatment period.

Measured over 2 weeks comparison between treatments
Peristomal skin condition
Lasso di tempo: Comparison between treatments over a 2-week period.

Participants will complete a short questionnaire which evaluates peristomal skin condition at the beginning and end of each treatment period.

Comparison between treatments over a 2-week period.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

30 aprile 2025

Completamento primario (Effettivo)

3 gennaio 2026

Completamento dello studio (Effettivo)

3 gennaio 2026

Date di iscrizione allo studio

Primo inviato

26 marzo 2025

Primo inviato che soddisfa i criteri di controllo qualità

2 aprile 2025

Primo Inserito (Effettivo)

6 aprile 2025

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

12 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • UUREC/24/0074
  • MR W029561 (Altro numero di sovvenzione/finanziamento: Medical Research Council)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .